GLPwatch
Trials (2081)
Page 19 of 35.
- Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)
- A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the Body
- Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
- Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease
- A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906
- COMMETS- Combination MCI Metabolic Syndrome
- Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
- Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
- A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight
- Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes
- Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients
- Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function
- Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance
- Identifying Potential Effects of Liraglutide on Degenerative Changes
- A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight
- Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
- Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes
- Binge Eating Liraglutide Intervention
- Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.
- Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
- Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
- PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
- A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices
- Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
- This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mineral Supplements- in Preventing Micronutrient Deficiencies Among Patients Utilizing GLP-1 RAs for Weight Loss in Comparison to a Placebo Control
- A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks
- Special Use - Results Surveillance on Long-term Use With Wegovy®
- A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease
- Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
- Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
- Visualizing Beta Cells After Islet Transplantation
- Plasma Glucagon-like Peptide-1 Levels and In-hospital Complications in ST-segment Elevation Myocardial Infarction
- Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)
- Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitus
- The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
- Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
- Oral Semaglutide in Patients With Alzheimer's Disease
- Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
- A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®
- A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
- A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes
- Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
- Bariatric Surgery vs. Semaglutide vs. Tirzepatide
- iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)
- Triple Therapy in T1DM
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)
- Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria
- JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
- To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
- The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
- A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
- A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
- Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
- Semaglutide for Helping Opioid Recovery
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
- A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity